DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences

TORONTO, May 10, 2023 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI" or "the Trust") today announced that the Trust intends to participate in the following investor conferences in spring 2023:

RBC Global Healthcare Conference

Date: May 17, 2023 
Presentation time: 2:30 pm ET 
City: New York, New York

UBS Spring Biotech Conference

Date: May 23, 2023 
Investor 1×1 meetings only 
City: New York, New York

Scotiabank Health and Wellness Conference

Date: May 31, 2023 
Presentation time: TBD 
City: Toronto, Ontario

About DRI Healthcare Trust

DRI Healthcare Trust is managed by DRI Capital Inc. ("DRI Capital"), the pioneer in global pharmaceutical royalty monetization with a more than 30-year history of accelerating innovation by providing capital to inventors, academic institutions and biopharma companies. Since its founding in 1989, DRI Capital has deployed more than US$2.5 billion, acquiring more than 70 royalties on 40-plus drugs, including Eylea, Spinraza, Zytiga, Remicade, Keytruda and Stelara. DRI Healthcare Trust’s units are listed and trade on the Toronto Stock Exchange in Canadian dollars under the symbol "DHT.UN" and in U.S. dollars under the symbol "DHT.U". To learn more, visit drihealthcare.com or follow us on LinkedIn.

SOURCE DRI Healthcare Trust


Recent Posts

2023 Third Quarter Earnings Call

DRI Healthcare Trust Reports Third Quarter 2023 Results

DRI Healthcare Trust Announces Upsized US$500 Million Credit Facili...